Grant: Collaborative Health Research Projects
University of Toronto
$67,525.00
MEMS-based closed-loop drug delivery devices integrating stimulus-responsive nano hydrogels: Design, fabrication, and testing
FY 2008-09
Summary
Diabetes is among the most important health care challenges worldwide. In Canada alone, two-three million
people have diabetes, of which 80% die as a result of diabetic complications such as heart disease. For diabetes
care, insulin administration through subcutaneous injection or insulin pumps is the most widely used method.
However, the persistence of vascular and other diabetic complications as the main cause of morbidity and
mortality calls for the improvement of insulin delivery technologies that allow for controlling insulin delivery
rates in real time based on time-varying glucose levels of individual patients.
Currently existing prototype systems that employ continuous glucose sensors in combination with insulin
pumps are not yet capable of providing safe and effective closed-loop insulin delivery. The cost of constructing
and maintaining such a delivery system is also rather high. Besides insulin delivery, the avoidance of severe
hypoglycemia that can lead to fainting, coma, and death, is also critically important to glucose control in
diabetes care. Severe hypoglycaemia occurs in diabetes because of defective release of insulin-counteracting
(counterregulatory) hormones, particularly glucagon.
In this project, glucose-responsive nano-hydrogels will be synthesized and integrated with MEMS
(microelectromechanical systems) structures to form new types of closed-loop insulin and glucagon delivery
devices. These compact micro devices will provide self-regulated insulin delivery to improve glucose control
and self-regulated glucagon delivery to avoid hypoglycemia in selected patients. Through design optimization
of MEMS structures and nano-hydrogel synthesis, improvement of glucose control and minimization of
hypoglycaemia in diabetic animals (rats) will be demonstrated, which will prompt further testing in large
animals and perhaps in humans.
Program
Collaborative Health Research Projects
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
338494-2007
Name nom
Sun, Yu
Department département
Mechanical and Industrial Engineering
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2008
Competition year année de concours
2007
Award amount
67525
Program id
CHRPJ
Program nane en
Collaborative Health Research Projects
Program name fr
Projets de recherche concertée sur la santé
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
360
Committee name en
Collaborative Health Research Projects Selection Panel
Committee name fr
Comité de sélection de projets de recherche concertée sur la santé
Area of application code
515
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Instrumentation technology
Area of application fr
Technologie de l'instrumentation
Research subject code
1700
Research subject group en
Design and manufacturing
Research subject group fr
Conception et fabrication
Research subject en
Design and manufacturing
Research subject fr
Conception et fabrication
Partie
2
Nb partie
3
Application title
MEMS-based closed-loop drug delivery devices integrating stimulus-responsive nano hydrogels: Design, fabrication, and testing
Keyword
NA
Application summary
Diabetes is among the most important health care challenges worldwide. In Canada alone, two-three million
people have diabetes, of which 80% die as a result of diabetic complications such as heart disease. For diabetes
care, insulin administration through subcutaneous injection or insulin pumps is the most widely used method.
However, the persistence of vascular and other diabetic complications as the main cause of morbidity and
mortality calls for the improvement of insulin delivery technologies that allow for controlling insulin delivery
rates in real time based on time-varying glucose levels of individual patients.
Currently existing prototype systems that employ continuous glucose sensors in combination with insulin
pumps are not yet capable of providing safe and effective closed-loop insulin delivery. The cost of constructing
and maintaining such a delivery system is also rather high. Besides insulin delivery, the avoidance of severe
hypoglycemia that can lead to fainting, coma, and death, is also critically important to glucose control in
diabetes care. Severe hypoglycaemia occurs in diabetes because of defective release of insulin-counteracting
(counterregulatory) hormones, particularly glucagon.
In this project, glucose-responsive nano-hydrogels will be synthesized and integrated with MEMS
(microelectromechanical systems) structures to form new types of closed-loop insulin and glucagon delivery
devices. These compact micro devices will provide self-regulated insulin delivery to improve glucose control
and self-regulated glucagon delivery to avoid hypoglycemia in selected patients. Through design optimization
of MEMS structures and nano-hydrogel synthesis, improvement of glucose control and minimization of
hypoglycaemia in diabetic animals (rats) will be demonstrated, which will prompt further testing in large
animals and perhaps in humans.